A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

The New England Journal of Medicine
F L JohnsonR Storb

Abstract

The progress of 24 children with acute lymphoblastic leukemia treated with cyclophosphamide, total-body irradiation, and marrow transplantation during a second or subsequent remission was compared with that of 21 children treated with conventional chemotherapy after they had entered a second remission. Eleven of the transplantation group are alive, including nine in continuing complete remission for 17 to 55 months; only two of the chemotherapy group are alive, one in complete remission after 20 months. Relapse was the major cause of failure in both groups. Acute and chronic graft-versus-host disease in the transplantation group and leukoencephalopathy in both groups were the other major causes of morbidity and mortality. This study demonstrates that marrow transplantation currently offers the best chance of long-term remission and potential cure after a child with acute lymphoblastic leukemia has had a relapse in the marrow.

References

Sep 1, 1979·Transplantation·R A CliftB W Goodell
Apr 17, 1975·The New England Journal of Medicine·E ThomasC D Buckner
Jan 1, 1979·Medical and Pediatric Oncology·J M Chessells, M Cornbleet
Sep 13, 1979·The New England Journal of Medicine·E D ThomasP L Weiden
Apr 11, 1975·Cancer·B G LeventhalE S Henderson
May 8, 1980·The New England Journal of Medicine·K G BlumeJ L Wolf
Feb 8, 1980·JAMA : the Journal of the American Medical Association·R P Gale
Sep 4, 1980·The New England Journal of Medicine·J A HansenE R Giblett

❮ Previous
Next ❯

Citations

Jul 1, 1993·Indian Journal of Pediatrics·T S Vats
Oct 1, 1983·Clinics in Haematology·R Storb, G W Santos
Aug 8, 1998·British Journal of Haematology·J M Chessells
Jan 26, 1984·The New England Journal of Medicine·F L Johnson, E D Thomas
Nov 8, 1984·The New England Journal of Medicine·A D Jacobs, R P Gale
Mar 23, 1995·The New England Journal of Medicine·F L Johnson, E D Thomas
Jun 1, 1982·British Journal of Haematology·R D Barr, J A McBride
Oct 1, 1993·Acta Paediatrica Japonica; Overseas Edition·M OchockaD Michalewska
Jan 23, 1982·Lancet
Jan 1, 1984·Cancer Investigation·K M Sullivan, R Storb
May 1, 1989·The American Journal of the Medical Sciences·W R VoglerD S Gordon
Jul 1, 1985·Mayo Clinic Proceedings·E C RosenowF R Cockerill
Oct 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Arend von StackelbergUNKNOWN ALL-REZ BFM Study Group
Jan 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W S MinF M Uckun
Dec 1, 1991·Pediatric Annals·J E Sanders
Jun 1, 1983·Pediatric Annals·C Lenarsky, S A Feig
Mar 10, 1992·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·S Asano
Jan 1, 1990·Critical Reviews in Oncology/hematology·D R Miller, L P Miller
Jan 1, 1986·Current Problems in Cancer·M M Bortin
Oct 1, 1982·British Journal of Haematology·A J BarrettJ R Hobbs
May 1, 1989·British Journal of Haematology·A Butturini, R P Gale
Jun 1, 1984·British Journal of Haematology·H J DeegE D Thomas
Jul 1, 1983·British Journal of Haematology·R E DinsmoreR J O'Reilly
Mar 1, 1983·British Journal of Haematology·J M Chessells
Jan 1, 1983·Critical Reviews in Oncology/hematology·L P Miller, D R Miller
Feb 1, 1988·Seminars in Oncology Nursing·T O'Quin, C Moravec
Feb 1, 1988·Seminars in Oncology Nursing·F M Wiley, K U House
Nov 1, 1982·The American Journal of Medicine·C A SklarN K Ramsay
Dec 30, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Merav BarElihu H Estey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.